Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucosamine Sulfate + Chondroitin Sulfate With Twin Block in Skeletal Class II Malocclusion
DRKS00028975Phase 3Completed
- Sponsor
- Damascus University
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Skeletal Class II malocclusion comparing Twin block + glucosamine sulfate/chondroitin sulfate gel with Twin block + placebo gel (2 arms). Started May 2022; status: completed.
02
Drugs
glucosamine sulphatechondroitin sulfate
03
Conditions
Skeletal Class II malocclusion
Beyond the preview
Go deeper on DRKS00028975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00028975.